Asked by Familly Arzate on May 07, 2024

verifed

Verified

The treatment team discusses adding a new prescription for lisdexamfetamine dimesylate to the plan of care for a patient diagnosed with binge eating disorder. Which finding from the nursing assessment is most important for the nurse to share with the team?

A) The patient's history of poly-substance abuse
B) The patient's preference for homeopathic remedies
C) The patient's family history of autoimmune disorders
D) The patient's comorbid diagnosis of a learning disability

Lisdexamfetamine Dimesylate

A medication primarily used to treat ADHD and binge eating disorder, known for its stimulant effects on the nervous system.

Binge Eating Disorder

An eating disorder characterized by recurrent episodes of eating large quantities of food, often rapidly and to the point of discomfort.

Poly-Substance Abuse

The concurrent misuse or dependence on multiple psychoactive substances, often leading to increased behavioral and health risks.

  • Gain insight into the potential coexisting conditions and difficulties related to eating disorders, along with their influence on physiological and psychological health.
verifed

Verified Answer

JS
Jasmine SanchezMay 10, 2024
Final Answer :
A
Explanation :
Lisdexamfetamine dimesylate is designed to suppress the appetite and presents a risk for abuse. The patient with a history of substance abuse is at risk to abuse this medication as well. The patient's preference for homeopathic remedies is a consideration, but the history of substance abuse has a higher priority. Lisdexamfetamine dimesylate is commonly used to treat attention deficit hyperactivity disorder rather than learning disabilities. A history of autoimmune disorders in the family is irrelevant.